Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 7
2017 2
2018 5
2019 9
2020 4
2021 13
2022 12
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Gonzales-Luna et al.
Gargis AS, Karlsson M, Kamile Rasheed J, Kent AG, McKay SL, Paulick AL, Anderson KF, Adamczyk M, Campbell D, Korhonen LC, McAllister G, Vlachos N, Halpin AL, Lutgring JD, Guh AY, Clifford McDonald L, Elkins CA. Gargis AS, et al. Among authors: halpin al. Clin Infect Dis. 2023 Jun 8;76(11):2039-2041. doi: 10.1093/cid/ciad133. Clin Infect Dis. 2023. PMID: 36883575 No abstract available.
Genomics for antimicrobial resistance surveillance to support infection prevention and control in health-care facilities.
Jauneikaite E, Baker KS, Nunn JG, Midega JT, Hsu LY, Singh SR, Halpin AL, Hopkins KL, Price JR, Srikantiah P, Egyir B, Okeke IN, Holt KE, Peacock SJ, Feasey NA; SEDRIC Genomics Surveillance Working Group. Jauneikaite E, et al. Among authors: halpin al. Lancet Microbe. 2023 Dec;4(12):e1040-e1046. doi: 10.1016/S2666-5247(23)00282-3. Epub 2023 Nov 14. Lancet Microbe. 2023. PMID: 37977161 Free article. Review.
Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group.
Baker KS, Jauneikaite E, Nunn JG, Midega JT, Atun R, Holt KE, Walia K, Howden BP, Tate H, Okeke IN, Carattoli A, Hsu LY, Hopkins KL, Muloi DM, Wheeler NE, Aanensen DM, Mason LCE, Rodgus J, Hendriksen RS, Essack SY, Egyir B, Halpin AL, MacCannell DR, Campos J, Srikantiah P, Feasey NA, Peacock SJ; SEDRIC Genomics Surveillance Working Group. Baker KS, et al. Among authors: halpin al. Lancet Microbe. 2023 Dec;4(12):e1035-e1039. doi: 10.1016/S2666-5247(23)00281-1. Epub 2023 Nov 14. Lancet Microbe. 2023. PMID: 37977164 Free article. Review.
Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019.
Kracalik I, Ham DC, McAllister G, Smith AR, Vowles M, Kauber K, Zambrano M, Rodriguez G, Garner K, Chorbi K, Cassidy PM, McBee S, Stoney RJ, Moser K, Villarino ME, Zazueta OE, Bhatnagar A, Sula E, Stanton RA, Brown AC, Halpin AL, Epstein L, Walters MS; Verona Integron-Encoded Metallo-β-Lactamase–Producing Carbapenem-Resistant Pseudomonas aeruginosa Medical Tourism Investigation Team2. Kracalik I, et al. Among authors: halpin al. Emerg Infect Dis. 2022 Jan;28(1):51-61. doi: 10.3201/eid2801.211880. Emerg Infect Dis. 2022. PMID: 34932447 Free PMC article. Review.
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
Gargis AS, Karlsson M, Paulick AL, Anderson KF, Adamczyk M, Vlachos N, Kent AG, McAllister G, McKay SL, Halpin AL, Albrecht V, Campbell D, Korhonen LC, Elkins CA, Rasheed JK, Guh AY, McDonald LC, Lutgring JD; Emerging Infections Program C. difficile Infection Working Group. Gargis AS, et al. Among authors: halpin al. Clin Infect Dis. 2023 Mar 4;76(5):890-896. doi: 10.1093/cid/ciac817. Clin Infect Dis. 2023. PMID: 36208202 Free PMC article.
Framing Bacterial Genomics for Public Health (Care).
Halpin AL, McDonald LC, Elkins CA. Halpin AL, et al. J Clin Microbiol. 2021 Nov 18;59(12):e0013521. doi: 10.1128/JCM.00135-21. Epub 2021 Jun 2. J Clin Microbiol. 2021. PMID: 34076468 Free PMC article.
Correction for Paulick et al., "Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank".
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Among authors: halpin al. Microbiol Resour Announc. 2022 May 19;11(5):e0030222. doi: 10.1128/mra.00302-22. Epub 2022 Apr 27. Microbiol Resour Announc. 2022. PMID: 35475673 Free PMC article. No abstract available.
60 results